by editor | Aug 1, 2019 | Clinicians, Media, Participants, Researchers
Landmark study to assess long-term health risks and benefits of prior aspirin use in elderly PRESS RELEASE Landmark ASPREE study extended for five years to track study participants for long-term health outcomes after discontinuing aspirin. ASPREE-XT will...
by editor | Feb 20, 2019 | Clinicians, Participants, Researchers
A welcome to Melbourne Australian ASPREE investigators welcomed members from the National Cancer Institute (NCI) to the School of Public Health and Preventive Medicine, Monash University late last month. Pictured above: ASPREE investigators and researchers from...
by editor | Feb 14, 2019 | Clinicians, Researchers
The ASPREE Aftermath: A Geriatric Perspective on the Role of Aspirin in Older Adults Thanks to permission from the American College of Cardiology, we are pleased to share this physician-penned article on the importance of the ASPREE study and the...
by editor | Sep 17, 2018 | Clinicians, Participants, Researchers
Daily low-dose aspirin doesn’t reduce heart-attack risk in healthy people For decades, doctors have been prescribing low-dose aspirin for healthy people over the age of 70. from shutterstock.com John McNeil, Monash University Taking low-dose aspirin daily...
by editor | Dec 20, 2017 | Clinicians, Participants
Study updates across south-eastern Australia in 2017, more to come From Wollongong to Burnie, members of our team were delighted to meet thousands of ASPREE participants and guests during 24 presentations held across south-eastern Australia this year....
Recent Comments